Reminder: Martek to Host Investor Conference Call to Discuss Research Presented at the International Conference on Alzheimer's Disease in Vienna, Austria

Monday, July 13, 2009 8:02 AM

COLUMBIA, Md., July 13/PRNewswire-FirstCall/ --Martek Biosciences Corporation (Nasdaq: MATK) will conduct a conference call for investors to discussDHA research recently presented at the International Conference on Alzheimer's Disease. The call will take place July 13, 2009, at approximately 9 a.m. Eastern Time (ET). All interested parties may listen to the call live via webcast by visiting Martek's web site at http://investors.martek.com.

An archived webcast of the conference call will be available on the Martek's website for thirty days. In addition, a recorded playback of the call will be available for one week and can be accessed by calling 800-633-8284 or 402-977-9140 and entering pass code 214 31512.

Martek Biosciences Corporation is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The Company produces life'sDHA(TM), a sustainable and vegetarian source of DHA omega-3, for use in foods, beverages, infant formula and supplements, and life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com/.

    CONTACT
           Kyle Stults
           Investor Relations
           (410) 740-0081
           investors@martek.com

SOURCE Martek Biosciences Corporation

(Source: PR Newswire )

Related Stories